This library blog is an electronic current awareness bulletin for doctors in training to help them stay current with up-to-date health-related research news, useful resources and more!
Thursday, June 28, 2007
Drug derived from sea squirt shows anti-tumour activity
An article published early online on 21 June 2007 in the The Lancet Oncology "Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study" concluded that the drug, trabectedin, derived from sea-squirt shows anti-tumour activity in more than half of patients with advanced pre-treated myxoid liposarcomas, a specific type of cancer associated with chromosomal translocations. Read more.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment